Branded strains reduce migraines in 60% of patients, says IMC

Mugglehead
By Nick LabaJun 24, 2020, 7:21 pm334 pts
A study shows two branded IM Cannabis Corp. (CSE: IMCC) strains reduced migraines in over 60 per cent of patients. The study was conducted by professor Dedi Meiri at the Israeli Institute of Technology, also known as Technion, and its results were presented in a statement on Wednesday. IMC has been growing and…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

US House Committee Approves Bill to Close THCA ‘Loophole,’ Ban Intoxicating Hemp Products 33

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.